SCHEMBL505619

SCHEMBL505619

O=C1C=CC(=O)N1CC1CCC(S)(C(=O)ON2C(=O)CC(S(=O)(=O)O)C2=O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847165 0.86
SCHEMBL28407286 0.85
SCHEMBL4620757 0.82
SCHEMBL22635959 0.82
SCHEMBL45106 0.82
SCHEMBL2810989 0.81
SCHEMBL29406614 0.81
SCHEMBL706497 0.78
SCHEMBL15940395 0.77
SCHEMBL563320 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8802450-B2 Fluorescent methods and materials for directed biomarker signal amplification SIRIGEN, INC. (US) 2014-08-12 US claimed
US-8158444-B2 Fluorescent methods and materials for directed biomarker signal amplification SIRIGEN, INC. (GB) 2012-04-17 US claimed
US-20120028828-A1 Fluorescent Methods and Materials for Directed Biomarker Signal Amplification SIRIGEN INC. (US) 2012-02-02 US claimed
EP-2164988-A2 FLUORESCENT METHODS AND MATERIALS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION Sirigen Inc. (US) 2010-03-24 EP claimed
US-20080293164-A1 Fluorescent Methods and Materials for Directed Biomarker Signal Amplification SIRIGEN INC. 2008-11-27 US claimed
WO-2008100344-A2 FLUORESCENT METHODS AND MATERIALS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION SIRIGEN INC. (US) 2008-08-21 WO claimed
US-20240102996-A1 Methods and Systems for Providing Labelled Biomolecules BECTON, DICKINSON AND COMPANY 2024-03-28 US disclosed
US-20240069019-A1 MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES BECTON, DICKINSON AND COMPANY 2024-02-29 US disclosed
EP-3981819-B1 NOVEL REAGENTS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION SIRIGEN II LTD (GB) 2024-02-28 EP disclosed
EP-2526138-B1 NOVEL REAGENTS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION SIRIGEN II LTD (GB) 2024-02-28 EP disclosed
EP-4322238-A2 NOVEL REAGENTS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION Sirigen II Limited (GB) 2024-02-14 EP disclosed
US-11899018-B2 Reagents for directed biomarker signal amplification SIRIGEN II LIMITED (GB) 2024-02-13 US disclosed
US-20240019434-A1 MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES CELLULAR RESEARCH, INC. 2024-01-18 US disclosed
US-20110256550-A1 Novel reagents for directed biomarker signal amplification SIRIGEN, INC. (US) 2011-10-20 US disclosed
US-20110256549-A1 Novel reagents for directed biomarker signal amplification SIRIGEN, INC. (US) 2011-10-20 US disclosed
WO-2011091086-A1 NOVEL REAGENTS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION SIRIGEN INC. (US) 2011-07-28 WO disclosed
WO-2010151807-A1 SIGNAL AMPLIFIED BIOLOGICAL DETECTION WITH CONJUGATED POLYMERS SIRIGEN, INC. (US) 2010-12-29 WO disclosed
EP-2164988-A2 FLUORESCENT METHODS AND MATERIALS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION Sirigen Inc. (US) 2010-03-24 EP disclosed
US-20080293164-A1 Fluorescent Methods and Materials for Directed Biomarker Signal Amplification SIRIGEN INC. 2008-11-27 US disclosed
WO-2008100344-A2 FLUORESCENT METHODS AND MATERIALS FOR DIRECTED BIOMARKER SIGNAL AMPLIFICATION SIRIGEN INC. (US) 2008-08-21 WO disclosed